Dear measles and rubella vaccine delivery and implementation experts,
WHO is soliciting your expertise on the potential need and use for microarray patches (MAPs) (otherwise known as microneedles or microneedle patches) to deliver measles and rubella vaccines (MR), particularly in the context of existing MR vaccine presentations in low resource settings.
Our hypothesis is that novel delivery technologies, such as MAPs, will be required to increase equitable coverage of measles and rubella vaccines to achieve control and elimination goals. MR-MAPs are in the early stages of clinical development and have several stages to pass through before becoming available. However, understandinghow these products will be used in the context of existing MR vaccines is crucial to informing the potential demand within immunization programmes, and bringing MR-MAPs to market.
For this reason, WHO is requesting your input through completion of this survey to 1) understand the situations in which MR-MAPs would be used and 2) identify the associated critical product attributes for MR-MAPs to allow for broad implementation in low and middle-income countries.
We kindly ask you to complete the survey below before the 6th of March. The survey should take around 10 minutes of your time.
Mateusz Hasso-Agopsowicz, MSc, PhD
Vaccine Product & Delivery Research
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
20 Ave Appia | 1211 Geneva | Switzerland